๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Essential Thrombocythaemia

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Miami Incyte Corporation ยท Tests: INCA033989, Ruxolitinib A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms NCT07849231Phase 136 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Duarte Damora Therapeutics ยท Tests: DMR-001, Ruxolitinib MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial NCT06786234Phase 214 sites๐Ÿ“ Poitiers๐Ÿ“ Brest๐Ÿ“ Marseille Step Pharma, SAS ยท Tests: STP938 Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients NCT04655092Phase 36 sites๐Ÿ“ Toon-shi๐Ÿ“ Tsu๐Ÿ“ Suita-shi PharmaEssentia Japan K.K. ยท Tests: P1101 (Ropeginterferon alfa-2b) Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes NCT06361641NA3 sites๐Ÿ“ Angers๐Ÿ“ Cholet๐Ÿ“ Saumur University Hospital, Angers ยท Tests: Monocytes signatures in myeloproliferative neoplasms at diagnosis Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera NCT06516406n/a26 sites๐Ÿ“ Cosenza๐Ÿ“ Reggio Calabria๐Ÿ“ Naples IRCCS Azienda Ospedaliero-Universitaria di Bologna Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis NCT06770842Phase 21 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Ropeginterferon alfa-2b (BESREMiยฎ) A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia NCT07623200Phase 3193 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Duarte Incyte Corporation ยท Tests: INCA033989, Best Available Treatment Therapeutic RSK1 Targeting in Myeloid Malignancies NCT07379125Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: PMD-026 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia NCT05320198Phase 1, Phase 235 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Disc Medicine, Inc ยท Tests: DISC-0974 Safety and Tolerability of ZE74-0282 in Healthy Volunteers NCT07527221Phase 11 site๐Ÿ“ Randwick Eilean Therapeutics AU Pty Ltd ยท Tests: ZE74-0282-0001 or placebo A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) NCT06351631Phase 321 sites๐Ÿ“ Ann Arbor๐Ÿ“ Durham๐Ÿ“ Columbus Merck Sharp & Dohme LLC ยท Tests: Bomedemstat A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) NCT07357727Phase 3148 sites๐Ÿ“ Denver๐Ÿ“ New Haven๐Ÿ“ Fort Myers Novartis Pharmaceuticals ยท Tests: Pelabresib, Ruxolitinib, Placebo An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms NCT05123365Phase 1, Phase 22 sites๐Ÿ“ Irvine๐Ÿ“ Orange University of California, Irvine ยท Tests: N-Acetylcysteine A Study of GLB-001 in Patients With Myeloid Malignancies NCT06378437Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Hangzhou GluBio Pharmaceutical Co., Ltd. ยท Tests: GLB-001 Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms NCT04282187Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration, Pacritinib MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites๐Ÿ“ Chicago๐Ÿ“ New York MPN Research Foundation Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms NCT07469891Phase 122 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ Denver Prelude Therapeutics Incorporated ยท Tests: PRT12396 Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. NCT05440838n/a6 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Nantes University Hospital, Angers ยท Tests: Next-generation sequencing Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986n/a1 site๐Ÿ“ Brussels Universitรฉ Catholique de Louvain Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites๐Ÿ“ Birmingham๐Ÿ“ Irvine๐Ÿ“ Los Angeles Incyte Corporation ยท Tests: INCA036978, Standard disease-directed therapy Two Step Haplo With Radiation Conditioning NCT05031897Phase 21 site๐Ÿ“ Philadephia Thomas Jefferson University ยท Tests: Fludarabine, Total-Body Irradiation, Donor Lymphocyte Infusion, Cyclophosphamide, Tacrolimus MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial NCT06541249Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Methotrexate (MTX) Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Observational A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms NCT07008118Phase 126 sites๐Ÿ“ Phoenix๐Ÿ“ Palo Alto๐Ÿ“ Denver Incyte Corporation ยท Tests: INCA035784 National Longitudinal Cohort of Hematological Diseases NCT04645199n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China Peginterferon ฮฑ-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia NCT06881056NA2 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Second University Hospital ยท Tests: Peginterferon ฮฑ-2b injection, Peginterferon ฮฑ-2b injection, symptomatic and supportive treatment
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy